A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women.
Letrozole has been studied across 19 research domains including 🧬 Hormones, 🔬 Oncology, ♀♂ Sexual Health, 💪 Strength & Power, ⏳ Longevity & Aging. The primary research focus is 🧬 Hormones with 49% of studies addressing this area.
The following compounds share molecular targets with Letrozole, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Letrozole is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.